CTLA4 mediates antigen-specific apoptosis of human T cells.
John G. Gribben(Queen Mary University of London), G S Gray(Dana-Farber Cancer Institute), Xiao-Yen Ke(Harvard University), Paul D. Rennert(Integrated BioTherapeutics (United States)), Vincent A. Restivo(Dana-Farber Cancer Institute), Melissa A. Barber(Harvard University), Gordon J. Freeman(Dana-Farber Cancer Institute), C L Jellis(Dana-Farber Cancer Institute), Edward Greenfield(Harvard University), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center)
Cited by 326
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k